STOCK TITAN

iTonic Holdings (ITOC) Stock Price, News & Analysis

ITOC NASDAQ

Ticker history: PTHL became ITOC (iTonic Holdings Ltd) on . Earlier news and filings retain their original names and dates. View PTHL history.

Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
82 252 sessions, November 13, 2025 to November 13, 2026
Largest daily move
+105% close of January 15, 2026
1-year change
-79.8% closing prices, November 13, 2025 to November 13, 2026
1-month change
-49.7% closing prices, October 13, 2026 to November 13, 2026

Company Description

iTonic Holdings Ltd (ITOC) provides healthcare solutions for brachytherapy, a targeted form of radiation therapy used in cancer treatment. The company operates through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., and focuses on treatment planning systems and related products and services used in brachytherapy procedures.

The company's lead product is Beijing Feitian's Treatment Planning System. The system supports planning for brachytherapy, in which radioactive sources are placed inside the patient to kill cancer cells and shrink tumors. iTonic's reported product portfolio also includes medical auxiliary supplies associated with brachytherapy procedures, such as seed implant needles, computer workstations and patient positioning devices.

iTonic Holdings was founded in 1998 and is based in Beijing, China. Its Class A ordinary shares are associated with Nasdaq listing requirements, including the minimum bid price rule disclosed in the company's public communications. The company's public-company profile is therefore defined by both its China-based healthcare-technology operating subsidiary and its status as a listed issuer reporting corporate, governance and capital-structure matters.

Stock Performance

$2.22
+12.12%
+0.24
After hoursChange vs the $1.98 closeLast updated: November 13, 2026 at 17:21
-79.8%
Performance 1 year
$16.2M

iTonic Holdings (ITOC) closed at $1.98 on November 13, 2026. Over the past 12 months, the price has lost 79.8%.

See what a $1,000 investment in ITOC would be worth today

Average down calculator for ITOC

ITOC Metrics & Rankings

Price returns through November 13, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Financial Highlights

iTonic Holdings generated $523K in revenue in FY2025, retaining a 62.6% gross margin, operating income reached -$5.2M, and net income was -$5.1M. Diluted earnings per share stood at -$0.32. The company generated -$3.2M in operating cash flow. The current ratio was 8.83, measuring current assets divided by current liabilities.

$523K
Revenue (FY2025)
-$5.1M
Net Income (FY2025)
-$3.2M
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for ITOC.

Short Interest History

Last 12 Months

Short interest in iTonic Holdings (ITOC) currently stands at 4.0 thousand shares, down 59.9% from the previous reporting period, representing 0.1% of the float.

Days to Cover History

Last 12 Months

Days to cover for iTonic Holdings (ITOC) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 4.1 days.

ITOC Company Profile & Sector Positioning

iTonic Holdings (ITOC) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the NASDAQ.

Investors comparing ITOC often look at related companies in the same sector, including SANUWAVE Health, Inc. (SNWV), PAVmed Inc. (PAVM), CVRx, Inc. (CVRX), Cytosorbents Corp. (CTSO), and Iridex Corp (IRIX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ITOC's relative position within its industry.

Frequently Asked Questions

The current stock price of iTonic Holdings (ITOC) is $2.22 in after-hours trading as of November 13, 2026.

The market cap of iTonic Holdings (ITOC) is approximately $16.2M. Learn more about what market capitalization means .

The FY2025 revenue of iTonic Holdings (ITOC) is $523K, from its most recent completed fiscal year.

The FY2025 net income of iTonic Holdings (ITOC) is -$5.1M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of iTonic Holdings (ITOC) is -$0.32 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of iTonic Holdings (ITOC) is -$3.2M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The gross profit margin of iTonic Holdings (ITOC) is 62.6% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of iTonic Holdings (ITOC), current assets divided by current liabilities, was 8.83 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of iTonic Holdings (ITOC) is $327K for FY2025, its most recent completed fiscal year.

The operating income of iTonic Holdings (ITOC) is -$5.2M for FY2025, its most recent completed fiscal year. Learn about operating income.

iTonic Holdings Ltd provides healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment.

The company operates through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd.

Its lead product is Beijing Feitian's Treatment Planning System, which supports treatment planning for brachytherapy procedures involving radioactive sources placed inside the patient.

The company's reported product portfolio includes medical auxiliary supplies such as seed implant needles, computer workstations and patient positioning devices.

iTonic Holdings Ltd is based in Beijing, China.

iTonic Holdings Ltd was founded in 1998.

The company's public disclosures refer to its Class A ordinary shares and Nasdaq listing requirements.